45
Markets2h 51m ago

Eli Lilly agreed to buy AtaiBeckley in a deal worth up to $3.8 billion, causing GH Research and Definium Therapeutics stocks to rise.

United States

Who
Eli Lilly,GH Research,Definium Therapeutics,AtaiBeckley
What
Eli Lilly agreed to buy AtaiBeckley in a deal worth up to $3.8 billion, causing GH Research and Definium Therapeutics stocks to rise.
When
Thu, 16 Jul 2026 16:36:18 GMT · 2h 51m ago
Where
United States ·
Why
The acquisition of AtaiBeckley by Eli Lilly is the direct cause for the stock movements of GH Research and Definium Therapeutics.
The Frontline Impact

How this affects you

The acquisition of AtaiBeckley by Eli Lilly for up to $3.8 billion has led to an increase in the stock prices of GH Research and Definium Therapeutics.

Story chain

1 event in this thread
No related history yet - this is the origin event.

Verified Sources & Citations

Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.